BCN-PEG4-OH is a hydroxyl-terminated ADC linker featuring BCN for fast, copper-free click chemistry, improving hydrophilicity and stability in antibody-drug conjugate design.
Structure of
* For research and manufacturing use only. We do not sell to patients.
Size | Price | Stock | Quantity |
---|---|---|---|
-- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
BCN-PEG4-OH, a versatile bifunctional linker, finds diverse applications in bioconjugation. Here are four key applications of BCN-PEG4-OH, presented with high perplexity and burstiness:
Bioorthogonal Chemistry: Serving as a pivotal tool in bioorthogonal labeling, BCN-PEG4-OH enables precise and selective chemical modifications within biological systems. The strain-promoted azide-alkyne cycloaddition (SPAAC) reaction facilitates swift and biocompatible labeling of biomolecules. This method empowers the exploration of dynamic biological processes in live cells and organisms, all while preserving the integrity of native biochemical pathways.
Drug Delivery Systems: BCN-PEG4-OH plays a crucial role in conjugating therapeutic agents to targeting ligands, thereby enhancing the specificity and efficacy of drug delivery. The incorporation of a PEG4 spacer imparts solubility and diminishes immunogenicity, thereby enhancing the pharmacokinetic properties of the conjugates. This application holds immense promise for developing targeted therapies that promise enhanced effectiveness with minimized side effects.
Protein/Peptide Conjugation: Enabling precise site-specific conjugation of proteins and peptides, BCN-PEG4-OH fuels a myriad of research and therapeutic endeavors. By linking therapeutic peptides to carrier proteins or other molecules, this linker boosts stability and bioactivity, paving the way for novel biologics and vaccine candidates designed with heightened efficacy and potency.
Diagnostic Imaging: BCN-PEG4-OH emerges as a potent tool for crafting imaging probes tailored for diagnostic applications. By conjugating imaging agents like fluorophores or radionuclides with biomolecules, it enables targeted imaging of specific tissues or cellular components. This technology proves instrumental in early disease detection and monitoring, particularly for conditions like cancer and inflammatory ailments.
Catalog | Product Name | CAS | Inquiry |
---|---|---|---|
BADC-01226 | BCN-PEG3-Biotin | 1263166-92-2 | |
BADC-00959 | BCN-PEG4-HyNic | 1507370-54-8 | |
BADC-00415 | BCN-PEG4-NHS ester | 1702356-19-1 | |
BADC-01019 | BCN-PEG4-acid | 1881221-47-1 | |
BADC-01096 | BCN-PEG3-VC-PFP ester | 2353409-45-5 | |
BADC-01224 | BCN-PEG1-Val-Cit-OH | ||
BADC-01225 | BCN-PEG1-Val-Cit-PABC-OH | ||
BADC-01227 | BCN-PEG3-oxyamine | ||
BADC-01228 | BCN-PEG3-Val-Cit | ||
BADC-01230 | BCN-PEG4-Ts |
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.